BioNexus Gene Lab Corp. Securities Borrowed, Allowance for Credit Loss
BioNexus Gene Lab Corp. (BGLC) had Securities Borrowed, Allowance for Credit Loss of $671.78 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Credit Losses
us-gaap:SecuritiesBorrowedAllowanceForCreditLoss · last filed 2025-11-14
- 2025-09-30: Securities Borrowed, Allowance for Credit Loss $671.78K.
- 2025-06-30: Securities Borrowed, Allowance for Credit Loss $494.67K.
- 2025-03-31: Securities Borrowed, Allowance for Credit Loss $523.51K.
- 2024-12-31: Securities Borrowed, Allowance for Credit Loss $517.88K; Securities Borrowed, Allowance for Credit Loss as first filed $508.54K.
| Period end | Securities Borrowed, Allowance for Credit Loss | Securities Borrowed, Allowance for Credit Loss as first filed |
|---|---|---|
| 2025-09-30 | $671.78K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $494.67K 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $523.51K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $517.88K 10-Q · filed 2025-11-14 | $508.54K 10-K · filed 2025-04-15 |
| 2024-09-30 | $596.33K 10-Q · filed 2024-11-15 | |
| 2024-06-30 | $851.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.36M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.31M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.32M 10-Q/A · filed 2024-03-26 | |
| 2023-06-30 | $291.94K 10-Q · filed 2023-08-16 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |